Defining the role of the tumor microenvironment in treatment resistance of OVArian cancer through patient-Derived EXplants (OVADEX)

Project Information

OVADEX

Grant agreement ID: 101064216

DOI

10.3030/101064216

Project closed

EC signature date 9 June 2022

Start date 1 September 2022

End date 31 August 2024

Funded under

• Marie Skłodowska-Curie Actions (MSCA)

Total cost

No data

EU contribution

€ 175 920,00

Coordinated by

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (1)

Communication, Dissemination & Outreach Plan

The plan describes the planned measures to maximize the impact ofthe project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and publicengagement strategy, the aim is to inform and reach out to society and show theactivities performed, and the use and the benefits the project will have for citizens

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cyclefor all data sets that will be collected processed or generated by the action It is adocument describing what data will be collected processed or generated andfollowing what methodology and standards whether and how this data will beshared andor made open and how it will be curated and preserved

Publications

Peer reviewed articles (3)

An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)

Author(s): Trozzi, Rita; Tuyaerts, Sandra; Annibali, Daniela; Pomares, Alejandro Herreros; Boog, Lotte; Van Dam, Peter; Leunen, Karin; Deroose, Christophe; Trum, Hans; Amant, Frederic
Published in: International Journal Of Gynecological Cancer, Issue 34 (8), 1217-1224, 2024, ISSN 1525-1438
Publisher: BMJ PUBLISHING GROUP
DOI: 10.1136/IJGC-2023-005229

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6^high uterine leiomyosarcoma to PD‐1 blockade

Author(s): Wout De Wispelaere; Daniela Annibali; Sandra Tuyaerts; Julie Messiaen; Asier Antoranz; Gautam Shankar; Nikolina Dubroja; Alejandro Herreros‐Pomares; Regina E. M. Baiden‐Amissah; Marie‐Pauline Orban; Marcello Delfini; Emanuele Berardi; Thomas Van Brussel; Rogier Schepers; Gino Philips; Bram Boeckx; Maria Francesca Baietti; Luigi Congedo; Kiave Yune HoWangYin; Emilie Bayon; Anne‐Sophie Van Rompuy; Eleonora Leucci; Sebastien P. Tabruyn; Francesca Bosisio; Massimiliano Mazzone; Diether Lambrechts; Frédéric Amant
Published in: Clinical and Translational Medicine, Vol 14, Iss 5, Pp n/a-n/a (2024), Issue 14(5) e1655, 2024, ISSN 2001-1326
Publisher: JONH WILEY & SONS LTD
DOI: 10.1002/CTM2.1655

Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer

Author(s): María Castaño; Sarai Tomás-Pérez; Eva González-Cantó; Cristina Aghababyan; Andrea Mascarós-Martínez; Nuria Santonja; Alejandro Herreros-Pomares; Julia Oto; Pilar Medina; Martin Götte; Bárbara Andrea Mc Cormack; Josep Marí-Alexandre; Juan Gilabert-Estellés
Published in: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Issue 24(6), 5995, 2023, ISSN 1661-6596
Publisher: MDPI
DOI: 10.3390/IJMS24065995